Literature DB >> 26825307

Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer.

Bettina M Knoll1, Lisa C Lindesmith2, Boyd L Yount2, Ralph S Baric2, Francisco M Marty3.   

Abstract

Norovirus gastroenteritis in immunocompromised hosts can result in a serious and prolonged diarrheal illness. We present a case of chronic norovirus disease during rituximab-bendamustine chemotherapy for non-Hodgkin's lymphoma. We show for the first time a correlation between norovirus strain-specific antibody blockade titers and symptom improvement in an immunocompromised host.

Entities:  

Keywords:  Immunocompromised host; Norovirus; Strain-specific antibody blockade titers

Mesh：

Substances：

Year:  2016        PMID： 26825307     DOI： 10.1007/s15010-016-0875-1

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  15 in total

1.  Norovirus gastroenteritis successfully treated with nitazoxanide.

Authors:  Danish M Siddiq; Hoonmo L Koo; Javier A Adachi; George M Viola
Journal:  J Infect       Date:  2011-08-09       Impact factor: 6.072

2.  Norovirus classification and proposed strain nomenclature.

Authors:  Du-Ping Zheng; Tamie Ando; Rebecca L Fankhauser; R Suzanne Beard; Roger I Glass; Stephan S Monroe
Journal:  Virology       Date:  2005-12-15       Impact factor: 3.616

3.  B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

Authors:  Jennifer H Anolik; Jonathan W Friedberg; Bo Zheng; Jennifer Barnard; Teresa Owen; Emily Cushing; Jennifer Kelly; Eric C B Milner; Richard I Fisher; Iñaki Sanz
Journal:  Clin Immunol       Date:  2006-09-27       Impact factor: 3.969

4.  Bendamustine can severely impair T-cell immunity against cytomegalovirus.

Authors:  Toru Hosoda; Akihiro Yokoyama; Mie Yoneda; Ryusuke Yamamoto; Kota Ohashi; Toshiya Kagoo; Hironori Ueno; Saigen Boku; Takahiro Yano
Journal:  Leuk Lymphoma       Date:  2012-11-15

5.  Serological correlate of protection against norovirus-induced gastroenteritis.

Authors:  Amanda Reeck; Owen Kavanagh; Mary K Estes; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

6.  Characteristics of human calicivirus enteritis in intestinal transplant recipients.

Authors:  Stuart S Kaufman; Nando K Chatterjee; Meghan E Fuschino; Dale L Morse; Raffaella A Morotti; Margret S Magid; Gabriel E Gondolesi; Sander S Florman; Thomas M Fishbein
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-03       Impact factor: 2.839

7.  Cellular and humoral immunity following Snow Mountain virus challenge.

Authors:  Lisa Lindesmith; Christine Moe; Jacques Lependu; Jeffrey A Frelinger; John Treanor; Ralph S Baric
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Authors:  Lisa C Lindesmith; Martina Beltramello; Eric F Donaldson; Davide Corti; Jesica Swanstrom; Kari Debbink; Antonio Lanzavecchia; Ralph S Baric
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

9.  Foodborne illness acquired in the United States--major pathogens.

Authors:  Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

10.  Novel GII.12 norovirus strain, United States, 2009-2010.

Authors:  Everardo Vega; Jan Vinjé
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883
View more
  6 in total

1.  Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis.

Authors:  Taojun He; Tracy A McMillen; Yuanyuan Qiu; Liang Hua Chen; Xuedong Lu; Xiao-Li Pang; Mini Kamboj; Yi-Wei Tang
Journal:  J Mol Diagn       Date:  2017-08-12       Impact factor: 5.568

2.  Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.

Authors:  Sreejesh Shanker; Rita Czakó; Gopal Sapparapu; Gabriela Alvarado; Maria Viskovska; Banumathi Sankaran; Robert L Atmar; James E Crowe; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

Review 3.  The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.

Authors:  Jessica M van Loben Sels; Kim Y Green
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

Review 4.  Viral gastroenteritis.

Authors:  Krisztián Bányai; Mary K Estes; Vito Martella; Umesh D Parashar
Journal:  Lancet       Date:  2018-06-29       Impact factor: 79.321

Review 5.  Serological Humoral Immunity Following Natural Infection of Children with High Burden Gastrointestinal Viruses.

Authors:  Mark R Zweigart; Sylvia Becker-Dreps; Filemón Bucardo; Fredman González; Ralph S Baric; Lisa C Lindesmith
Journal:  Viruses       Date:  2021-10-09       Impact factor: 5.048

Review 6.  Norovirus in Cancer Patients: A Review.

Authors:  Divya Samantha Kondapi; Sasirekha Ramani; Mary K Estes; Robert L Atmar; Pablo C Okhuysen
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.